Literature DB >> 20732325

Development of a second generation Inhibin B ELISA.

Bhanu Kalra1, Ajay Kumar, Kinita Patel, Amita Patel, M J Khosravi.   

Abstract

Inhibins are heterodimeric protein hormones secreted by the granulosa cells of the ovary in the female and the Sertoli cells of the testis in the male. Published research studies have assessed Inhibin B levels in Sertoli cell function, ovarian reserve and granulosa cell tumors. A two-step sandwich-type enzymatic microplate assay to measure Inhibin B levels within 3.5h is reported, and sample pre-treatment is not required. The assay measures Inhibin B in 50 μL of serum or Li-Hep plasma sample against Inhibin B calibrators (10-1000 pg/mL). The highly characterized antibody pair used in the assay measures 100% Inhibin B and no response was detected above the sensitivity of the assay with Inhibin A, Activin A, Activin B, Activin AB, AMH, FSH, LH or Follistatin 315 at the concentrations tested. The second generation Inhibin B assay was compared against two commercially available assays using 60 male and 60 female samples, ranging in age from 20 to 50 years. The assay showed significant positive linear correlations to Oxford Brooks Innovation (OBI) and Diagnostics Systems Laboratories (DSL) assays (r=0.99; P<0.0001; and r=0.97; P<0.0001), respectively. Method comparison to OBI and DSL resulted in the following slope and intercept (Gen II=1.03 OBI-6.77 pg/mL and Gen II=1.57 DSL+11.29 pg/mL), respectively. Matched serum and Li-Hep plasma samples (n=120) showed a correlation coefficient of >0.99 and a slope of 0.97 with zero intercept. Total imprecision calculated on three samples and two controls over 40 runs, three replicates per run, using NCCLS EP5-A guidelines was 6.8% at 19.34 pg/mL, 4.4% at 76.03 pg/mL, 4.3% at 275.3 pg/mL, 5.4% at 99.88 pg/mL, and 5.7% at 363.9 pg/mL. The LoQ for the assay at 20% CV was 4.8 pg/mL. Dilution and spiking studies showed an average recovery of 90-110%. A highly specific, sensitive, simplified and reproducible microplate Inhibin B assay has been developed to measure Inhibin B in serum and Li-Hep plasma. The performance of the assay is ideal for investigation into the physiologic role of Inhibin B in both men and women.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732325     DOI: 10.1016/j.jim.2010.08.002

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Inhibin B and luteinizing hormone levels in girls aged 6-11 years from NHANES III, 1988-1994.

Authors:  Emily K Sims; O Y Addo; Audra L Gollenberg; John H Himes; Mary L Hediger; Peter A Lee
Journal:  Clin Endocrinol (Oxf)       Date:  2012-10       Impact factor: 3.478

2.  Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle.

Authors:  John F Randolph; Siobán D Harlow; Margaret E Helmuth; Huiyong Zheng; Daniel S McConnell
Journal:  Hum Reprod       Date:  2013-12-18       Impact factor: 6.918

3.  Short-term energy deprivation alters activin a and follistatin but not inhibin B levels of lean healthy women in a leptin-independent manner.

Authors:  Vasiliki A Moragianni; Konstantinos N Aronis; John P Chamberland; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

4.  Sildenafil increases serum testosterone levels by a direct action on the testes.

Authors:  M Spitzer; S Bhasin; T G Travison; M N Davda; H Stroh; S Basaria
Journal:  Andrology       Date:  2013-09-18       Impact factor: 3.842

5.  Serum inhibin B for differentiating between congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty: a systematic review and meta-analysis.

Authors:  Yuting Gao; Qin Du; Liyi Liu; Zhihong Liao
Journal:  Endocrine       Date:  2021-01-19       Impact factor: 3.633

Review 6.  Spreading the clinical window for diagnosing fetal-onset hypogonadism in boys.

Authors:  Romina P Grinspon; Nazareth Loreti; Débora Braslavsky; Clara Valeri; Helena Schteingart; María Gabriela Ballerini; Patricia Bedecarrás; Verónica Ambao; Silvia Gottlieb; María Gabriela Ropelato; Ignacio Bergadá; Stella M Campo; Rodolfo A Rey
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-07       Impact factor: 5.555

7.  Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation.

Authors:  Rachel B Danis; Intira Sriprasert; Jacqueline R Ho; Lynda K McGinnis; Ajay Kumar; Frank Z Stanczyk
Journal:  F S Rep       Date:  2021-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.